drugset / Trial / NCT03993314

Optimizing Anesthesia for Post Partum Tubal Ligations

NCT03993314

Phase 2 Terminated 15 enrolled University of Alabama at Birmingham
RandomizedParallel-groupDouble-blindTreatment

Summary

In this study, the investigators will compare CLOROTEKAL® (1% spinal chloroprocaine) to low-dose isobaric bupivacaine using the epidural volume extension (EVE) technique in patients undergoing post-partum tubal ligation (PPBTL). This will be a randomized, double-blinded study. Patients scheduled for PPBTL at the Women and Infants Center (WIC) will be eligible for enrollment in this study. Outcomes measured will include: ability to achieve an adequate level required for surgery (T6), rate of epidural activation, and duration of the block. The investigators hope to determine the usefulness of each drug using the EVE technique in the setting of PPBTL.

Timeline

Start
2019-08-13
Primary completion
2020-12-03
Completion
2020-12-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 5 mg Intrathecal
Subject Chloroprocaine Other / unclassified 50 mg Intrathecal
Comparator Fentanyl Other / unclassified 15 ug Intrathecal

Indications